Pharmacy Focus27 Jun 2024

S2 Ep26: Public Health Matters: Generative AI and the Future of Pharmacy

In this episode, host Dr. Christina Madison interviews Dr. Bolu Oladini, PharmD, author, global medical affairs, generative AI medical content lead, Pfizer, to discuss the intersections of pharmacy, medical affairs, and AI. Dr. Oladini describes the importance of following one’s interest, and using those passions to one’s advantage when building on a career. Both Dr. Madison and Dr. Oladini also share the importance of understanding AI sources and prompts when using the available interfaces.
Key Takeaways:

Embrace Non-Traditional Career Paths: Dr. Bolu Oladini emphasizes the importance of pharmacists exploring non-traditional roles, rather than confining themselves to conventional pharmacy roles. He discusses his journey to further describe how individuals can use their personal interests and skills to help open or forge unique career opportunities.
The Role of Medical Affairs: Medical affairs involve communicating complex medical and product data to various stakeholders, including health care providers, patients, and regulators. This space is about ensuring that scientific data is accurately conveyed and that patient interests are prioritized, often serving as a balance to marketing efforts.
The Potential of Artificial Intelligence in Pharmacy: AI, notably generative AI, is set to revolutionize various aspects of the pharmaceutical industry, from automating repetitive tasks in pharmacies to aiding in drug discovery and enhancing medical content creation. The episode highlights the importance of staying curious and experimental with AI to fully realize its potential in improving healthcare outcomes.

You can preorder Dr. Bolu Oladini’s book here. He can be found on the following social media platforms:

LinkedIn: @Bolu Oladini
Instagram: @doctor_bolu
Facebook: @Bolu Oladini
X (formerly known as Twitter): @doctor_bolu
TikTok: @doctor_bolu

You can check out the following discussed AI platforms:

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(356)

S2 Ep92: Beyond CRS and ICANS: Managing the Delayed Toxicities of Cilta-cel

Sara Scott, PharmD, BCOP, Emma Uchida, PharmD, MBA, BCOP, and Rebecca Gonzalez, PharmD, BCOP, gather for a roundtable on the rare, delayed toxicities associated with ciltacabtagene autoleucel in relap...

28 Aug 50min

S2 Ep91: Food, Fungals, and Flexibility: Real-World Dosing of Revumenib

26 Aug 25min

S2 Ep90: Introducing the Psychiatric Pharmacist Pulse Podcast

Megan Maroney, PharmD, BCPP, FAAPP: Hello, I'm Megan Maroney, and this is Psychiatric Pharmacy Pulse, a monthly podcast where we talk about hot topics in psychiatric pharmacy. I'm a clinical associate...

21 Aug 1min

S2 Ep89: Under the Skin: What Subcutaneous Isatuximab Means for Myeloma Care

Matthew Lei, PharmD, BCOP, a clinical oncology pharmacist at Massachusetts General Hospital, joins Pharmacy Focus: Oncology Edition to break down the FDA approval of subcutaneous isatuximab-irfc via t...

20 Aug 31min

S2 Ep88: CMSC 2026 Highlights: Biomarkers, DMT Discontinuation, and Pregnancy Planning in MS

In this episode of Mind the Meds, host Erica Marini, PharmD, MS, BCPS, welcomes Jenelle Hall Montgomery, PharmD, BCACP, CPP, a clinical pharmacist practitioner with Duke Neurological Disorders Clinic ...

6 Aug 54min

S2 Ep87: EP. 1: Introducing Pharmacy Focus: Financial Wellness—Building Your Rich Life

Have a question, feedback, or an idea for a future episode? Contact YFP Wealth at info@yfpwealth.com. To learn more about fee-only financial planning services for pharmacists, visit yfpwealth.com.This...

3 Aug 10min

S2 Ep86: Untangling Holistic, Integrative, Functional, and Precision Medicine in Oncology

Holistic, integrative, functional, precision—the labels are everywhere, but few patients or clinicians know where one ends and the next begins.

24 Jul 37min

S2 Ep84: Beyond Seizures: Phenobarbital's Clinically Significant Interaction Profile

To open the episode, Erica Marini, PharmD, discussed a roundup of FDA and research updates in neurology. She covered the shifting accelerated-approval pathway for AMT-130 (uniQure), a gene therapy for...

2 Jul 53min